8-Azaguanine

CAS No. 134-58-7

8-Azaguanine( —— )

Catalog No. M11388 CAS No. 134-58-7

8-Azaguanine is a purine analogs showing antineoplastic activity by competing with guanine in the metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 28 In Stock
100MG 36 In Stock
200MG 51 In Stock
500MG 85 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    8-Azaguanine
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Azaguanine is a purine analogs showing antineoplastic activity by competing with guanine in the metabolism.
  • Description
    8-Azaguanine is a purine analogs showing antineoplastic activity by competing with guanine in the metabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Purine nucleoside phosphorylase
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    134-58-7
  • Formula Weight
    152.11
  • Molecular Formula
    C4H4N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6 mg/mL (39.44 mM)
  • SMILES
    NC1=NC(=O)C2=NNNC2=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dourado M, et al. Pathophysiology, 2007, 14(1), 3-10.
molnova catalog
related products
  • Flavanomarein

    Flavanomarein demonstrates potent antioxidative property, including free radical scavenging activity, inhibition of lipid peroxidation, as well as lipid-lowering effects in human HepG2 hepatocellular carcinoma cells treated with free fatty acids (FFAs).

  • β-Neuroprotectin

    β-Neuroprotectin

  • Amylin (20-29) (huma...

    Amylin (20-29) (human) is the fragment of human islet amyloid polypeptide (hIAPP) or Amylin. Amylin is a 37-residue hormone. Amylin (20-29) (human) is responsible for the amyloidogenic propensities of the full length protein. Amylin (20-29) (human) can be transformed into its corresponding peptoid and retropeptoid sequences, to obtain beta-sheet breaker peptides as amyloid inhibitors.